Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
2025 Diseases of the Circulatory System Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the circulatory system ... Read More
-
Heart Failure Market by Type (Chronic Heart Failure, Acute Heart Failure), Therapeutic Drug, Distribution Channel, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... period. Heart Failure Market Overview Heart failure is a medical condition characterized by the heart's inability to pump blood effectively to meet the body's demands. This condition can result from various underlying issues such as ... Read More
-
Blood Flow Measurement Devices Market, By Product Type (Laser Doppler Blood Flowmeters, Ultrasonic Doppler Blood Flowmeters, and Electromagnetic Blood Flowmeters), By Application (Cardiovascular Disease, Tumor Monitoring, Gastroenterology, Diabetes, Dermatology, and Others), By End User (Hospital, Clinics, Ambulatory Surgical Centers, Specialty Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... heart failure, coronary artery disease etc has boosted demand for advanced blood flow measurement devices that helps achieve accurate diagnosis. Constant technological advancements in medical devices industry has led to development of non-invasive and minimally-invasive ... Read More
-
Europe Stroke Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (Europe)
... diagnostic tools are reshaping how strokes are identified and treated across the region. Projections indicate a robust growth path, with the market expected to reach US$ 1.08 Bn in 2025 and further expand to US$ ... Read More
-
2025 Global: Gene Therapy For Heart Failure Market - Innovative Markets Forecast (2031) report
... most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the ... Read More
-
2025 Global: Heart Disease Insurance Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
Acute Coronary Syndrome
... at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 16.2% CAGR The Acute Coronary Syndrome market in the U.S. ... Read More
-
Carotid Stents
... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Anticoagulants
... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More
-
Embolotherapy
... 7.7% over the analysis period 2024-2030. Embolic Agents, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$6.7 Billion by the end of the analysis period. Growth ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.8 Billion ... Read More
-
Cardiology IT Workflow Solutions
... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Cloud, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$1.1 Billion by the end ... Read More
-
Cholesterol Testing
... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More
-
Heart Failure Drugs
... at a CAGR of 12.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 16.3% CAGR The Heart Failure Drugs market in the U.S. ... Read More
-
Perfusion Systems
... CAGR of 4.4% over the analysis period 2024-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$671.0 Million by the end of the ... Read More
-
Acute Ischemic Stroke Diagnosis and Treatment
... reach US$3.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Computed Tomography, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach ... Read More
-
Critical Care Therapeutics
... at a CAGR of 5.7% over the analysis period 2024-2030. Albumin, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
Dilated Cardiomyopathy Therapeutics
... at a CAGR of 4.3% over the analysis period 2024-2030. Angiotensin II Receptor Blockers (ARBs), one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$258.2 Million by ... Read More
-
2025 Global Gene Therapy For Heart Failure Market Industry (2031 Outlook)
... size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Angina Pectoris Drugs
... at a CAGR of 4.5% over the analysis period 2024-2030. Beta Blockers, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.6 Billion by the end of ... Read More
-
Cardiovascular Ultrasound Systems
... at a CAGR of 5.1% over the analysis period 2024-2030. Stress Echocardiogram, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Heart Valve Repair and Replacement Devices
... reach US$40.9 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. Transcatheter Surgery, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach ... Read More
-
Stroke Management
... CAGR of 5.3% over the analysis period 2024-2030. Diagnostics Type, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$35.9 Billion by the end of the analysis ... Read More
-
Cardiovascular Health
... covers advancements in heart disease prevention, treatment, and management. Featured articles will include expert insights, clinical studies, protocols, and emerging products designed to support heart health, including innovations in medication, lifestyle interventions, and diagnostic technologies. Read More
Research Assistance
